CASP8 and small cell lung carcinoma: Shivapurkar et al. demonstrated that caspase 8 was inactive in small-cell lung cancer (SCLC) patients, and its absence was associated with cancer cell chemoresistance by stimulation of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) [21].